298 related articles for article (PubMed ID: 19725595)
21. Ciclosporin kinetics in children after stem cell transplantation.
Willemze AJ; Cremers SC; Schoemaker RC; Lankester AC; den Hartigh J; Burggraaf J; Vossen JM
Br J Clin Pharmacol; 2008 Oct; 66(4):539-45. PubMed ID: 18492124
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetics and pharmacogenetics of everolimus in renal transplant patients.
Moes DJ; Press RR; den Hartigh J; van der Straaten T; de Fijter JW; Guchelaar HJ
Clin Pharmacokinet; 2012 Jul; 51(7):467-80. PubMed ID: 22624503
[TBL] [Abstract][Full Text] [Related]
23. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.
Mao JJ; Jiao Z; Yun HY; Zhao CY; Chen HC; Qiu XY; Zhong MK
Br J Clin Pharmacol; 2018 Jan; 84(1):153-171. PubMed ID: 28891596
[TBL] [Abstract][Full Text] [Related]
24. Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients.
Lukas JC; Suárez AM; Valverde MP; Calvo MV; Lanao JM; Calvo R; Suarez E; Gil AD
J Clin Pharm Ther; 2005 Dec; 30(6):549-57. PubMed ID: 16336287
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
Han K; Bies R; Johnson H; Capitano B; Venkataramanan R
Clin Pharmacokinet; 2011 Mar; 50(3):201-14. PubMed ID: 21294597
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator.
Rousseau A; Léger F; Le Meur Y; Saint-Marcoux F; Paintaud G; Buchler M; Marquet P
Ther Drug Monit; 2004 Feb; 26(1):23-30. PubMed ID: 14749545
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
Barau C; Furlan V; Debray D; Taburet AM; Barrail-Tran A
Br J Clin Pharmacol; 2012 Sep; 74(3):515-24. PubMed ID: 22329639
[TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
[TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose.
Bergmann TK; Hennig S; Barraclough KA; Isbel NM; Staatz CE
Ther Drug Monit; 2014 Feb; 36(1):62-70. PubMed ID: 24089074
[TBL] [Abstract][Full Text] [Related]
30. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.
Han N; Yun HY; Hong JY; Kim IW; Ji E; Hong SH; Kim YS; Ha J; Shin WG; Oh JM
Eur J Clin Pharmacol; 2013 Jan; 69(1):53-63. PubMed ID: 22660440
[TBL] [Abstract][Full Text] [Related]
31. Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies.
Mao J; Jiao Z; Qiu X; Zhang M; Zhong M
Eur J Pharm Sci; 2020 Oct; 153():105471. PubMed ID: 32682934
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients.
van Hest RM; van Gelder T; Vulto AG; Shaw LM; Mathot RA
Clin Pharmacokinet; 2009; 48(7):463-76. PubMed ID: 19691368
[TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
Schädeli F; Marti HP; Frey FJ; Uehlinger DE
Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
[TBL] [Abstract][Full Text] [Related]
34. Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
Bourgoin H; Paintaud G; Büchler M; Lebranchu Y; Autret-Leca E; Mentré F; Le Guellec C
Br J Clin Pharmacol; 2005 Jan; 59(1):18-27. PubMed ID: 15606436
[TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of cyclosporine in clinical renal transplant patients.
Wu KH; Cui YM; Guo JF; Zhou Y; Zhai SD; Cui FD; Lu W
Drug Metab Dispos; 2005 Sep; 33(9):1268-75. PubMed ID: 15932953
[TBL] [Abstract][Full Text] [Related]
36. Population pharmacokinetics of mizoribine in adult recipients of renal transplantation.
Ishida K; Okamoto M; Ishibashi M; Hashimoto Y
Clin Exp Nephrol; 2011 Dec; 15(6):900-6. PubMed ID: 21751083
[TBL] [Abstract][Full Text] [Related]
37. Developmental pharmacokinetics of ciclosporin--a population pharmacokinetic study in paediatric renal transplant candidates.
Fanta S; Jönsson S; Backman JT; Karlsson MO; Hoppu K
Br J Clin Pharmacol; 2007 Dec; 64(6):772-84. PubMed ID: 17662086
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
39. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
Staatz CE; Tett SE
Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
[TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
